» Articles » PMID: 30760803

The Cyclic Peptide Labaditin Does Not Alter the Outer Membrane Integrity of Salmonella Enterica Serovar Typhimurium

Overview
Journal Sci Rep
Specialty Science
Date 2019 Feb 15
PMID 30760803
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial peptides are a promising class of new antibiotics with the ability to kill bacteria by disrupting their cell membrane, which is especially difficult for Gram-negative bacteria whose cell wall contains an outer layer of lipopolysaccharides (LPS). Here we show that the cyclic decapeptide Labaditin (Lo), with proven activity against the Gram-positive Staphylococcus aureus and Streptococcus mutans, is not able to kill the Gram-negative Salmonella enterica serovar Typhimurium (S.e.s. Typhimurium). We found that Lo induced significant changes in the surface pressure isotherms of Langmuir monolayers representing the Salmonella enterica serovar Typhimurium inner membrane (S.e.s. Typhimurium IM), and caused leakage in large unilamellar vesicles made with this IM lipid composition. On the basis of these results one should expect bactericidal activity against S.e.s. Typhimurium. However, Lo could not interact with a monolayer of LPS, causing no significant changes in either the surface pressure isotherms or in the polarization-modulated infrared reflection absorption spectra (PM-IRRAS). Therefore, the failure of Lo to kill S.e.s. Typhimurium is associated with the lack of interaction with LPS from the outer bacteria membrane. Our approach with distinct monolayer compositions and combined techniques to investigate molecular-level interactions is useful for drug design to fight antibiotic-resistant bacteria.

Citing Articles

Surface Chemistry of Cytosporone-B Incorporated in Models for Microbial Biomembranes as Langmuir Monolayers.

Jaroque G, Dos Santos A, Sartorelli P, Caseli L Langmuir. 2024; .

PMID: 39007866 PMC: 11295194. DOI: 10.1021/acs.langmuir.4c01575.


Antimicrobial activity, membrane interaction and structural features of short arginine-rich antimicrobial peptides.

Agrillo B, Porritiello A, Gratino L, Balestrieri M, Proroga Y, Mancusi A Front Microbiol. 2023; 14:1244325.

PMID: 37869668 PMC: 10585156. DOI: 10.3389/fmicb.2023.1244325.


The Antimicrobial Peptide 1018-K6 Interacts Distinctly with Eukaryotic and Bacterial Membranes, the Basis of Its Specificity and Bactericidal Activity.

Luisa Ambrosio R, Rossello C, Casares D, Palmieri G, Anastasio A, Escriba P Int J Mol Sci. 2022; 23(20).

PMID: 36293249 PMC: 9603936. DOI: 10.3390/ijms232012392.


Peptide Extracts from Native Lactic Acid Bacteria Generate Ghost Cells and Spheroplasts upon Interaction with , as Promising Food Antimicrobials.

Tenea G Biomed Res Int. 2020; 2020:6152356.

PMID: 33083475 PMC: 7559518. DOI: 10.1155/2020/6152356.

References
1.
Schwarz G, Taylor S . Polymorphism and interactions of a viral fusion peptide in a compressed lipid monolayer. Biophys J. 1999; 76(6):3167-75. PMC: 1300285. DOI: 10.1016/S0006-3495(99)77468-0. View

2.
Epand R, Vogel H . Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta. 1999; 1462(1-2):11-28. DOI: 10.1016/s0005-2736(99)00198-4. View

3.
Jackman J, Fierke C, Tumey L, Pirrung M, Uchiyama T, Tahir S . Antibacterial agents that target lipid A biosynthesis in gram-negative bacteria. Inhibition of diverse UDP-3-O-(r-3-hydroxymyristoyl)-n-acetylglucosamine deacetylases by substrate analogs containing zinc binding motifs. J Biol Chem. 2001; 275(15):11002-9. DOI: 10.1074/jbc.275.15.11002. View

4.
Gunn J . Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotoxin Res. 2001; 7(1):57-62. View

5.
Netea M, Kullberg B, Joosten L, Sprong T, Verschueren I, Boerman O . Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur J Immunol. 2001; 31(9):2529-38. DOI: 10.1002/1521-4141(200109)31:9<2529::aid-immu2529>3.0.co;2-b. View